Back
SELLAS Life Sciences Group Vs. Repligen Industry Stock Comparison
Sell
45
SLS
SELLAS Life Sciences Group
Last Price:
1.32
Seasonality Move:
7.89%
Sell
30
RGEN
Repligen
Last Price:
124.90
Seasonality Move:
7.3%
Sell
45
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.32. The Score for SLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLS is experiencing slight buying pressure.
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 60.02 | Buy |
| Chaikin Money Flow: | 343952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.28) | Buy |
| Bollinger Bands (100): | (1.16 - 1.28) | Buy |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 36.22 | Sell |
| Chaikin Money Flow: | -1285419 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.94 - 146.38) | Sell |
| Bollinger Bands (100): | (130 - 153.64) | Sell |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.25 | Buy |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.23 | Buy |
| 200-day SMA: | 1.22 | Buy |
| 8-day EMA: | 1.27 | Buy |
| 20-day EMA: | 1.23 | Buy |
| 50-day EMA: | 1.23 | Buy |
| 200-day EMA: | 1.25 | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.02 | Sell |
| 20-day SMA: | 140.23 | Sell |
| 50-day SMA: | 141.19 | Sell |
| 200-day SMA: | 157.58 | Sell |
| 8-day EMA: | 139.7 | Sell |
| 20-day EMA: | 140.54 | Sell |
| 50-day EMA: | 141.71 | Sell |
| 200-day EMA: | 151.3 | Sell |
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.04 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
SELLAS Life Sciences Group Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||